Literature DB >> 21923960

Synchronous ossiculoplasty with titanium prosthesis during canal wall down surgery for advanced cholesteatoma: anatomical and hearing outcomes.

M Iseri1, E Ustundag, A Ulubil, M Ozturk, O Bircan.   

Abstract

OBJECTIVE: To analyse patients with cholesteatoma undergoing canal wall down mastoidectomy together with ossicular reconstruction with a titanium prosthesis, in order to identify factors associated with hearing outcomes. STUDY
DESIGN: Retrospective review of 97 cases undergoing single-stage surgical management.
METHODS: All patients underwent canal wall down mastoidectomy. Kurz titanium ossicular prostheses were used for ossicular chain reconstruction. Pre-operative and post-operative air conduction and bone conduction hearing thresholds were obtained at 500, 1000, 2000 and 3000 Hz.
RESULTS: The mean pure tone average improved from 46.02 ± 14.54 dB pre-operatively to 29.32 ± 14.64 dB post-operatively, for both total and partial ossicular replacement prosthesis groups combined. The mean air-bone gap improved from 30.38 ± 11.12 dB pre-operatively to 15.62 ± 9.65 dB post-operatively, for both groups combined.
CONCLUSION: Reconstruction with a titanium prosthesis offers good functional results when performed during canal wall down surgery for advanced cholesteatoma, as a single-stage procedure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923960     DOI: 10.1017/S0022215111002520

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  The effects of surgery type and different ossiculoplasty materials on the hearing results in cholesteatoma surgery.

Authors:  Sultan Şevik Eliçora; Duygu Erdem; Aykut Erdem Dinç; Murat Damar; Sultan Bişkin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-11       Impact factor: 2.503

2.  Evaluation of functional results of CWD surgery with ossicular replacement prosthesis due to cholesteatoma using computed tomography.

Authors:  Selcuk Ucar; Mete Iseri; Murat Ozturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-06       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.